Kinase News and Research

RSS

SARS-CoV-2 viroporin triggers NLRP3 inflammasome causing a severe inflammatory response

Now, a team of researchers at the University of Florida report that the SARS-CoV-2 viroporin triggers the NLR Family Pyrin Domain Containing 3 (NLRP3) inflammasome, which is responsible for the inflammatory pathology in severely ill COVID-19 patients.

30 Oct 2020

Intercellular communication pathway drives motivation to seek cocaine

In the October 28, 2020 issue of the Journal of Neuroscience, researchers from the Medical University of South Carolina and the National Institutes of Health describe how reminders of drug use can change specific brain cells responsible for motivation, increasing the desire to seek drugs.

29 Oct 2020

Study: Mammary basal cell lineage contributes to breast cancer heterogeneity

A key hurdle in treating breast cancers is intratumoral heterogeneity, or the presence of multiple different cell populations within the same tumor that have distinct characteristics such as gene expression, metabolism and ability to divide, spread and grow.

29 Oct 2020

Genome-wide CRISPR screens reveal resistance and sensitization mechanisms of drugs used in COVID-19

By leveraging nucleotide triphosphate analog-induced cell death, Chinese researchers unveiled genes that affect the import, export, and metabolism of pervasively used antiviral drugs in the treatment of coronavirus disease (COVID-19). This exciting study is currently available on the bioRxiv* preprint server.

28 Oct 2020

Research on autophagy and coronavirus, implicates ULK1

Researchers from the University of British Columbia have discovered that the betacoronavirus-encoded papain-like protease disrupts autophagy, partly by targeting ULK1. Their work is reported on the preprint server bioRxiv* in October 2020.

27 Oct 2020

Exploring the role of insects as potential new food allergen

Those with food allergies must avoid allergens in food. Health problems can be triggered by even the smallest traces for those affected.

20 Oct 2020

Scientists discover key enzyme involved in the development of autoimmune diseases

Scientists affiliated with the Center for Research on Inflammatory Diseases (CRID http://crid.fmrp.usp.br), hosted by the University of São Paulo (USP) in Brazil, have discovered that an enzyme involved in key metabolic processes also plays a role in immune cell differentiation and hence in the development of autoimmune diseases.

19 Oct 2020

New tool can provide non-invasive decision support for NSCLC treatment

Personalized treatment options for patients with lung cancer have come a long way in the past two decades.

16 Oct 2020

UofSC scientists identify biological triggers that promote quicker nerve regeneration

University of South Carolina scientists are exploring ways to make nerve regeneration happen faster and more successfully.

15 Oct 2020

Study may lead to new therapies to improve survival in septic patients

Each year, some 270,000 Americans die from sepsis, in which the release of normally helpful infection-fighting chemicals in the body triggers an unusually extreme immune response - powerful enough to cause life-threatening damage to blood vessels and organs.

15 Oct 2020

Researchers discover a promising treatment for frequent form of blindness in the elderly

Researchers at Ghent University, Belgium, have found a promising treatment for the most frequent form of blindness in the elderly.

13 Oct 2020

Research uncovers a novel way of preventing or treating epilepsy

Epileptic seizures often originate in small, localized areas of the brain where neurons abnormally fire in unison.

8 Oct 2020

Case report of arthritis in a COVID-19 patient

The current paper published in the The Lancet Rheumatology discusses arthritis in a 58-year-old white woman with COVID-19 of less than severe intensity.

7 Oct 2020

Thiopurines could help stop viral replication in human coronaviruses

Researchers from the Department of Microbiology & Immunology, Dalhousie University, University of Calgary, and Department of Biochemistry and Molecular Biology, University of British Columbia, Canada, worked with human coronaviruses in cell cultures to look for drugs that might prevent accumulation and replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

6 Oct 2020

Study confirms SARS-CoV-2 spike glycoprotein promotes a hyper-inflammatory immune response

A group of researchers from Australia and China recently demonstrated how SARS-CoV-2 spike glycoprotein subunit 1 can induce a pro-inflammatory signaling pathway (leading to cytokines deployment and epithelial damage in human bronchial epithelial cells), but also highlighted the potential of peptide-based antivirals in tackling this novel coronavirus.

5 Oct 2020

Severe lymphatic disorder reversed through genetic sequencing and targeted treatment

Through genetic sequencing and targeted treatment, researchers from Children's Hospital of Philadelphia have resolved a severe lymphatic disorder in a young woman with kaposiform lymphangiomatosis (KLA), a complex and rare disorder that causes lymphatic vessels around the heart and lung to leak fluid, causing breathing difficulties, infections, and often death.

5 Oct 2020

Potential drug treatment for AXL-low expressing EGFR-mutated lung cancer

Researchers at Kanazawa University report in Nature Communications the mechanism making some lung-cancer patients resistant to the drug osimertinib.

5 Oct 2020

Discovery of specific kinase as a novel drug target against SARS-CoV-2 and other coronaviruses

By using a modern genome-wide knockout approach to single out coronavirus host factors in human cells, researchers from Rega Institute in Belgium discovered a potential new target that might be exploited for developing drugs against the ongoing coronavirus disease (COVID-19) pandemic, but also future outbreaks of highly pathogenic coronaviruses

29 Sep 2020

Researchers develop a new substance that can disarm tumor-promoting proteins

The villain in this drama has a pretty name: Aurora - Latin for dawn. In the world of biochemistry, however, Aurora (more precisely: Aurora-A kinase) stands for a protein that causes extensive damage. There, it has been known for a long time that Aurora often causes cancer.

29 Sep 2020

Life-threatening COVID-19 associated with specific genetic variants

Results of a genome-wide association study on 2,244 critically-ill patients due to coronavirus disease (COVID-19) from 208 intensive care units across the United Kingdom revealed significant host-specific genetic determinants that can predispose people to the severe form of the disease. The report is currently available on the medRxiv preprint server.

28 Sep 2020

Kinase News and Research

SARS-CoV-2 viroporin triggers NLRP3 inflammasome causing a severe inflammatory response

Intercellular communication pathway drives motivation to seek cocaine

Study: Mammary basal cell lineage contributes to breast cancer heterogeneity

Genome-wide CRISPR screens reveal resistance and sensitization mechanisms of drugs used in COVID-19

Research on autophagy and coronavirus, implicates ULK1

Exploring the role of insects as potential new food allergen

Scientists discover key enzyme involved in the development of autoimmune diseases

New tool can provide non-invasive decision support for NSCLC treatment

UofSC scientists identify biological triggers that promote quicker nerve regeneration

Study may lead to new therapies to improve survival in septic patients

Researchers discover a promising treatment for frequent form of blindness in the elderly

Research uncovers a novel way of preventing or treating epilepsy

Case report of arthritis in a COVID-19 patient

Thiopurines could help stop viral replication in human coronaviruses

Study confirms SARS-CoV-2 spike glycoprotein promotes a hyper-inflammatory immune response

Severe lymphatic disorder reversed through genetic sequencing and targeted treatment

Potential drug treatment for AXL-low expressing EGFR-mutated lung cancer

Discovery of specific kinase as a novel drug target against SARS-CoV-2 and other coronaviruses

Researchers develop a new substance that can disarm tumor-promoting proteins

Life-threatening COVID-19 associated with specific genetic variants

Measuring Drug-Target Residence Times with Biochemical Assays eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News